<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> (IFI) causes morbidity and mortality among patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> who receive cytotoxic chemotherapy or hematopoietic stem cell transplantation (HSCT) </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the incidence and treatment outcomes of proven and probable IFI in 22 institutions between 2006 and 2008 following the recent European Organization for Research and Treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>/<z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">Mycosis</z:e> Study Group (EORTC/MSG) consensus criteria </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed 2,821 patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, including 597 who had undergone HSCT; these included patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (n = 697), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (n = 284), <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 1465), or <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (n = 375) </plain></SENT>
<SENT sid="3" pm="."><plain>IFIs were diagnosed in 38 (1.3%) patients (18 proven and 20 probable), including 20 patients who underwent HSCT and 18 who received chemotherapy alone; these included patients with <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> (n = 23), <z:e sem="disease" ids="C0006840" disease_type="Disease or Syndrome" abbrv="">candidiasis</z:e> (n = 6), <z:e sem="disease" ids="C0026718" disease_type="Disease or Syndrome" abbrv="">mucormycosis</z:e> (n = 6), <z:e sem="disease" ids="C0343939" disease_type="Disease or Syndrome" abbrv="">trichosporonosis</z:e> (n = 2), and <z:e sem="disease" ids="C0017455" disease_type="Disease or Syndrome" abbrv="">geotrichosis</z:e> (n = 1) </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence of IFI was 5.4 % in allogeneic HSCT patients, 0.4 % in autologous HSCT patients, and 0.8 % in patients receiving chemotherapy alone </plain></SENT>
<SENT sid="5" pm="."><plain>Eighteen patients with <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> were diagnosed with probable pulmonary IFI as determined by computed tomography scan and positive galactomannan assay </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, antifungal targeted therapies resulted in successful outcomes in 60.0 % of patients </plain></SENT>
<SENT sid="7" pm="."><plain>IFI-attributable mortality rate was higher in HSCT patients than in those receiving chemotherapy alone, but the difference was not statistically significant </plain></SENT>
</text></document>